Citadel Advisors
DH icon

Citadel Advisors’s Definitive Healthcare DH Stock Holding History

Citadel Advisors’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,800
Closed -$33.9K – 13207
2025
Q4 		$33.9K Sell
11,800
-500
-4% -$1.39K ﹤0.01% 12186
2025
Q3 		$49.9K Sell
12,300
-6,600
-35% -$26.4K ﹤0.01% 12214
2025
Q2 		$73.7K Buy
18,900
+7,100
+60% +$22.4K ﹤0.01% 11552
2025
Q1 		$34.1K Buy
11,800
+9,500
+413% +$38.5K ﹤0.01% 12691
2024
Q4 		$9.45K Sell
2,300
-5,700
-71% -$24.9K ﹤0.01% 13647
2024
Q3 		$35.8K Sell
8,000
-35,000
-81% -$164K ﹤0.01% 12268
2024
Q2 		$235K Buy
43,000
+100
+0.2% +$630 ﹤0.01% 9601
2024
Q1 		$346K Buy
42,900
+27,600
+180% +$244K ﹤0.01% 9167
2023
Q4 		$152K Sell
15,300
-13,500
-47% -$106K ﹤0.01% 10357
2023
Q3 		$230K Buy
28,800
+800
+3% +$8.04K ﹤0.01% 9646
2023
Q2 		$308K Buy
28,000
+2,400
+9% +$24.7K ﹤0.01% 8994
2023
Q1 		$264K Sell
25,600
-6,100
-19% -$71.8K ﹤0.01% 9636
2022
Q4 		$348K Buy
31,700
+21,600
+214% +$278K ﹤0.01% 8987
2022
Q3 		$157K Buy
+10,100
New +$222K ﹤0.01% 10657

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors's DH Position: Q1 2026 in Review

Citadel Advisors increased its Definitive Healthcare (DH) stake by 49% in Q1 2026, buying an estimated $249K and bringing the position to 433,408 shares worth $533K. The position accounts for ﹤0.01% of the portfolio, ranked #9145.

Citadel Advisors first reported a position in DH in Q3 2021 and has held it in 15 quarters since. The position peaked at $23.2M in Q3 2021. 119 funds tracked by Wall St. Rank hold DH as of Q1 2026.

  • Citadel Advisors held 433,408 shares of Definitive Healthcare worth $533K as of Q1 2026.
  • Citadel Advisors bought 143,108 Definitive Healthcare shares in Q1 2026, an estimated $249K.
  • Definitive Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #9145 holding.
  • Citadel Advisors first reported a position in Definitive Healthcare in Q3 2021 and has held it in 15 quarters since.
  • Citadel Advisors's Definitive Healthcare position peaked at $23.2M in Q3 2021.
  • 119 funds tracked by Wall St. Rank held Definitive Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.